If angiotensinogen is produced at higher levels in adjacent cells one ofthe activating enzymes which convert the product of the AGTgene in angiotensin II (ACE) is instead higher in PIN andL-PCA, suggesting the potential for utilization in tumour cells at lower stagesof prostate cancer development. This evidence concerns the gene AGT and prostate cancer.